Response duration
| Duration of response∗ . | Phase 2 and Exp (n = 29) . | Phase 1b (n = 7) . |
|---|---|---|
| Response duration | ||
| No. of events | 19 | 4 |
| Median (95% CI) | 11.1 (5.6-41.4) | 14.6 (0.5-NE) |
| % without event at 6 months (95% CI) | 69 (49-82) | 57 (17-84) |
| % without event at 24 months (95% CI) | 38 (21-55) | 43 (10-73) |
| Median follow-up (range) | 34.2 (19.6-47.8) | 45.7 (43.1-52.3) |
| Duration of response∗ . | Phase 2 and Exp (n = 29) . | Phase 1b (n = 7) . |
|---|---|---|
| Response duration | ||
| No. of events | 19 | 4 |
| Median (95% CI) | 11.1 (5.6-41.4) | 14.6 (0.5-NE) |
| % without event at 6 months (95% CI) | 69 (49-82) | 57 (17-84) |
| % without event at 24 months (95% CI) | 38 (21-55) | 43 (10-73) |
| Median follow-up (range) | 34.2 (19.6-47.8) | 45.7 (43.1-52.3) |
Duration of response was calculated from the time of first response (CR/CRi) to progression or death, whichever occurred first; patients without event were censored at the time of last follow-up.